138 related articles for article (PubMed ID: 15270964)
1. Reversal of vecuronium with neostigmine in patients with diabetes mellitus.
Saitoh Y; Hattori H; Sanbe N; Nakajima H; Akatu M; Murakawa M
Anaesthesia; 2004 Aug; 59(8):750-4. PubMed ID: 15270964
[TBL] [Abstract][Full Text] [Related]
2. Reversal of vecuronium with neostigmine: a comparison between male and female patients.
Saitoh Y; Aoki K; Okazaki M; Hirama T; Isosu T; Murakawa M
Fukushima J Med Sci; 2009 Dec; 55(2):61-70. PubMed ID: 20608096
[TBL] [Abstract][Full Text] [Related]
3. Comparison of recovery following rapacuronium, with and without neostigmine, and succinylcholine.
Hayes A; Breslin D; Reid J; Mirakhur RK
Anaesthesia; 2000 Sep; 55(9):859-63. PubMed ID: 10947748
[TBL] [Abstract][Full Text] [Related]
4. Sugammadex provides faster reversal of vecuronium-induced neuromuscular blockade compared with neostigmine: a multicenter, randomized, controlled trial.
Khuenl-Brady KS; Wattwil M; Vanacker BF; Lora-Tamayo JI; Rietbergen H; Alvarez-Gómez JA
Anesth Analg; 2010 Jan; 110(1):64-73. PubMed ID: 19713265
[TBL] [Abstract][Full Text] [Related]
5. Early and late reversal of rocuronium and vecuronium with neostigmine in adults and children.
Bevan JC; Collins L; Fowler C; Kahwaji R; Rosen HD; Smith MF; de Scheepers LD; Stephenson CA; Bevan DR
Anesth Analg; 1999 Aug; 89(2):333-9. PubMed ID: 10439743
[TBL] [Abstract][Full Text] [Related]
6. [Effects of halothane and sevoflurane on reversal of neuromuscular blockade induced by vecuronium in man].
Izawa H; Takeda J; Fukushima K
Masui; 1997 Feb; 46(2):177-83. PubMed ID: 9071099
[TBL] [Abstract][Full Text] [Related]
7. Neostigmine-induced reversal of vecuronium in normal weight, overweight and obese female patients.
Suzuki T; Masaki G; Ogawa S
Br J Anaesth; 2006 Aug; 97(2):160-3. PubMed ID: 16782976
[TBL] [Abstract][Full Text] [Related]
8. Antagonism of vecuronium-induced neuromuscular block in patients pretreated with magnesium sulphate: dose-effect relationship of neostigmine.
Fuchs-Buder T; Ziegenfuss T; Lysakowski K; Tassonyi E
Br J Anaesth; 1999 Jan; 82(1):61-5. PubMed ID: 10325838
[TBL] [Abstract][Full Text] [Related]
9. Conditions to optimise the reversal action of neostigmine upon a vecuronium-induced neuromuscular block.
Baurain MJ; Dernovoi BS; D'Hollander AA; Hennart DA; Cantraine FR
Acta Anaesthesiol Scand; 1996 May; 40(5):574-8. PubMed ID: 8792887
[TBL] [Abstract][Full Text] [Related]
10. Neostigmine reversal of vecuronium neuromuscular block and the influence of renal failure.
Dhonneur G; Rebaine C; Slavov V; Ruggier R; De Chaubry V; Duvaldestin P
Anesth Analg; 1996 Jan; 82(1):134-8. PubMed ID: 8712389
[TBL] [Abstract][Full Text] [Related]
11. Time to peak effect of neostigmine at antagonism of atracurium- or vecuronium-induced neuromuscular block.
Kirkegaard-Nielsen H; Helbo-Hansen HS; Lindholm P; Severinsen IK; Bülow K
J Clin Anesth; 1995 Dec; 7(8):635-9. PubMed ID: 8747561
[TBL] [Abstract][Full Text] [Related]
12. Factors affecting neostigmine reversal of vecuronium block during sevoflurane anaesthesia.
Morita T; Kurosaki D; Tsukagoshi H; Shimada H; Sato H; Goto F
Anaesthesia; 1997 Jun; 52(6):538-43. PubMed ID: 9203879
[TBL] [Abstract][Full Text] [Related]
13. A randomised controlled trial comparing sugammadex and neostigmine at different depths of neuromuscular blockade in patients undergoing laparoscopic surgery.
Geldner G; Niskanen M; Laurila P; Mizikov V; Hübler M; Beck G; Rietbergen H; Nicolayenko E
Anaesthesia; 2012 Sep; 67(9):991-8. PubMed ID: 22698066
[TBL] [Abstract][Full Text] [Related]
14. Optimum time for neostigmine administration to antagonize vecuronium-induced neuromuscular blockade.
Kirkegaard-Nielsen H; Toft P; Severinsen IK; May O
Eur J Anaesthesiol; 1995 Nov; 12(6):585-9. PubMed ID: 8665881
[TBL] [Abstract][Full Text] [Related]
15. Sugammadex reversal of rocuronium-induced neuromuscular blockade: a comparison with neostigmine-glycopyrrolate and edrophonium-atropine.
Sacan O; White PF; Tufanogullari B; Klein K
Anesth Analg; 2007 Mar; 104(3):569-74. PubMed ID: 17312210
[TBL] [Abstract][Full Text] [Related]
16. Is recovery of neuromuscular transmission complete after the use of neostigmine to antagonize block produced by rocuronium, vecuronium, atracurium and pancuronium?
Baurain MJ; Hoton F; D'Hollander AA; Cantraine FR
Br J Anaesth; 1996 Oct; 77(4):496-9. PubMed ID: 8942335
[TBL] [Abstract][Full Text] [Related]
17. Optimum dose of neostigmine to reverse shallow neuromuscular blockade with rocuronium and cisatracurium.
Choi ES; Oh AY; Seo KS; Hwang JW; Ryu JH; Koo BW; Kim BG
Anaesthesia; 2016 Apr; 71(4):443-9. PubMed ID: 26874258
[TBL] [Abstract][Full Text] [Related]
18. Reversal of Partial Neuromuscular Block and the Ventilatory Response to Hypoxia: A Randomized Controlled Trial in Healthy Volunteers.
Broens SJL; Boon M; Martini CH; Niesters M; van Velzen M; Aarts LPHJ; Dahan A
Anesthesiology; 2019 Sep; 131(3):467-476. PubMed ID: 31045894
[TBL] [Abstract][Full Text] [Related]
19. Recovery of train-of-four ratio to 0.70 and 0.90 is delayed in type 2 diabetes with vecuronium-induced neuromuscular block.
Nitahara K; Sugi Y; Shigematsu K; Haraga I; Abe S; Higa K
Eur J Anaesthesiol; 2013 Feb; 30(2):80-4. PubMed ID: 23172246
[TBL] [Abstract][Full Text] [Related]
20. Coronary vasospasm during the reversal of neuromuscular block using neostigmine.
Kido K; Mizuta K; Mizuta F; Yasuda M; Igari T; Takahashi M
Acta Anaesthesiol Scand; 2005 Oct; 49(9):1395-6. PubMed ID: 16146484
[No Abstract] [Full Text] [Related]
[Next] [New Search]
